entity

C1QA, C1QB, C3, IL1B, NFKB1

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about C1QA, C1QB, C3, IL1B, NFKB1: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

1Connections
1Hypotheses
1Analyses
1Outgoing
0Incoming
1Experiments
1Debates

No AI portrait yet

Outgoing (1)

TargetRelationTypeStr
neurodegenerationpromoted: Complement-SASP Amplification Cascade as Mechanistic Linkdisease0.61

Incoming (0)

SourceRelationTypeStr
No incoming edges

Targeting Hypotheses (1)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
Complement-SASP Amplification Cascade as Mechanistic Link 0.741 neurodegeneration Why have anti-Aβ clinical trials failed

Mentioning Analyses (1)

Scientific analyses that reference this entity

Why have anti-Aβ clinical trials failed despite the established role of Aβ in AD

neurodegeneration | 2026-04-16 | 2 hypotheses Top: 0.741

Experiments (1)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
Single-cell RNA sequencing analysis of human atherosclerotic plaques exploratory Atherosclerosis 0.900 0.00 Human atherosclerotic plaque s proposed N/A

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found

Debates (1)

Multi-agent debates referencing this entity

The abstract suggests that Aβ-tau synergy could explain negative results from an

closed · Rounds: 4 · Score: 0.65 · 2026-04-16

Related Research

Hypotheses and analyses mentioning C1QA, C1QB, C3, IL1B, NFKB1 in their description or question text

No additional research found